|
| Status |
Public on Oct 01, 2011 |
| Title |
TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in human fibrosarcoma cells. |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Microarray analysis revealed differential gene expression patterns of HT1080 cells treated with various chemical compounds alone and in combination (trabectedin, doxorubicin, mafosfamide, TRAIL, taurolidine)
|
| |
|
| Overall design |
Microarray analysis of HT1080 cells treated with various chemical compounds alone and in combination (trabectedin, doxorubicin, mafosfamide, TRAIL, taurolidine)
|
| |
|
| Contributor(s) |
Harati K, Hahn S |
| Citation(s) |
22753761 |
| Submission date |
Sep 28, 2011 |
| Last update date |
Feb 22, 2018 |
| Contact name |
Kamran Harati |
| E-mail(s) |
kamran.harati@t-online.de
|
| Organization name |
BG University Hospital Ludwigshafen
|
| Department |
Department of Hand and Plastic Surgery, Burn Centre
|
| Street address |
Ludwig-Guttmanstrasse 13
|
| City |
Ludwigshafen |
| ZIP/Postal code |
67071 |
| Country |
Germany |
| |
|
| Platforms (1) |
| GPL4133 |
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version) |
|
| Samples (13)
|
|
| Relations |
| BioProject |
PRJNA147715 |
Less...
More...